Mineralys Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
CATALYS PACIFIC, LLC | 02/14/2025 | 8.64 M | $106.41 M | 0.00% | 17.30% |
SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 5.07 M | $62.47 M | 0.00% | 10.16% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 4.85 M | $59.72 M | 0.00% | 9.71% |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 2.47 M | $30.41 M | 0.00% | 4.94% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.14 M | $26.33 M | -0.26% | 4.28% |
SR ONE CAPITAL MANAGEMENT, LP | 02/13/2025 | 2.02 M | $24.83 M | 0.00% | 4.04% |
FRANKLIN RESOURCES INC | 02/12/2025 | 1.75 M | $21.49 M | 0.00% | 3.49% |
ORBIMED ADVISORS LLC | 02/14/2025 | 1.61 M | $19.84 M | -19.54% | 3.23% |
LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 1.41 M | $17.39 M | 0.00% | 2.83% |
ADAMS STREET PARTNERS LLC | 02/14/2025 | 1.13 M | $13.91 M | -26.28% | 2.26% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 1.08 M | $13.32 M | 55.40% | 2.17% |
CALIGAN PARTNERS LP | 02/14/2025 | 1.01 M | $12.45 M | 3.06% | 2.02% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 875,000 | $10.77 M | 145.79% | 1.75% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 848,630 | $10.45 M | -8.91% | 1.70% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 841,541 | $10.36 M | 15.37% | 1.68% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 650,023 | $8.00 M | 7.27% | 1.30% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 632,506 | $7.79 M | 0.00% | 1.27% |
STEMPOINT CAPITAL LP | 02/14/2025 | 400,101 | $4.93 M | 100.00% | 0.80% |
SECTORAL ASSET MANAGEMENT INC | 02/14/2025 | 380,883 | $4.69 M | 15.59% | 0.76% |
AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 350,000 | $4.31 M | 0.00% | 0.70% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 332,390 | $4.09 M | 84.66% | 0.67% |
CANDRIAM S.C.A. | 02/07/2025 | 305,272 | $3.76 M | 100.00% | 0.61% |
SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 190,672 | $2.35 M | -30.02% | 0.38% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 146,500 | $1.80 M | 0.00% | 0.29% |
PALE FIRE CAPITAL SE | 02/13/2025 | 136,897 | $1.69 M | 0.00% | 0.27% |
POLAR ASSET MANAGEMENT PARTNERS INC. | 02/25/2025 | 99,100 | $1.22 M | 144.69% | 0.20% |
NEOS INVESTMENT MANAGEMENT LLC | 02/12/2025 | 89,529 | $1.10 M | -27.51% | 0.18% |
02/14/2025 | 89,529 | $1.10 M | 100.00% | 0.18% | |
LION POINT CAPITAL, LP | 02/14/2025 | 79,000 | $972,490 | 0.00% | 0.16% |
ALPS ADVISORS INC | 02/13/2025 | 40,248 | $495,453 | 5.19% | 0.08% |
UBS OCONNOR LLC | 02/14/2025 | 28,068 | $345,517 | -9.66% | 0.06% |
PROFICIO CAPITAL PARTNERS LLC | 02/05/2025 | 23,192 | $23,192 | 100.00% | 0.05% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 17,786 | $218,946 | 100.00% | 0.04% |
LETKO, BROSSEAU & ASSOCIATES INC | 02/14/2025 | 16,500 | $203,115 | 44.74% | 0.03% |
BELLEVUE GROUP AG | 02/14/2025 | 16,499 | $203,103 | 0.00% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 16,383 | $201,675 | 4.36% | 0.03% |
QUEST PARTNERS LLC | 02/07/2025 | 15,222 | $187,383 | 2,637.77% | 0.03% |
MARTINGALE ASSET MANAGEMENT L P | 02/13/2025 | 14,965 | $184,220 | 0.00% | 0.03% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 14,197 | $174,765 | -7.01% | 0.03% |
ENTRYPOINT CAPITAL, LLC | 02/11/2025 | 12,487 | $153,715 | 100.00% | 0.03% |
CREATIVEONE WEALTH, LLC | 02/13/2025 | 10,750 | $132,333 | 0.00% | 0.02% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 10,553 | $129,907 | 10.34% | 0.02% |
02/11/2025 | 7,136 | $87,844 | 100.00% | 0.01% | |
VIRTUS ETF ADVISERS LLC | 02/14/2025 | 5,842 | $71,915 | -19.61% | 0.01% |
SMARTLEAF ASSET MANAGEMENT LLC | 02/05/2025 | 1,905 | $23,850 | 23.94% | 0.00% |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 1,658 | $21,256 | -7.84% | 0.00% |
GEOWEALTH MANAGEMENT, LLC | 02/13/2025 | 1,439 | $17,714 | 0.00% | 0.00% |
MEEDER ASSET MANAGEMENT INC | 02/12/2025 | 1,338 | $16,471 | 100.00% | 0.00% |
02/19/2025 | 1,045 | $12,864 | 100.00% | 0.00% | |
STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 723 | $8,900 | 838.96% | 0.00% |
Mineralys Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 61 institutional investors and hedge funds held shares of Mineralys Therapeutics, Inc.. The most heavily invested institutionals were:
Catalys Pacific, LLC: 8.64 M
Samsara BioCapital, LLC: 5.07 M
RA CAPITAL MANAGEMENT, L.P.: 4.85 M
TCG Crossover Management, LLC: 2.47 M
BlackRock Funding, Inc. /DE: 2.14 M
SR ONE CAPITAL MANAGEMENT, LP: 2.02 M
93.04% of Mineralys Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 40.37 M shares in the last 24 months. This purchase volume represents approximately $526.79 M in transactions.